These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26429585)

  • 1. Regenerated Cellulose Capsules for Controlled Drug Delivery, Part 2: Modulating Membrane Permeability by Incorporation of Depolymerized Cellulose and Altering Membrane Thickness.
    Bhatt B; Kumar V
    J Pharm Sci; 2015 Dec; 104(12):4266-4275. PubMed ID: 26429585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regenerated cellulose capsules for controlled drug delivery: Part IV. In-vitro evaluation of novel self-pore forming regenerated cellulose capsules.
    Bhatt B; Kumar V
    Eur J Pharm Sci; 2017 Jan; 97():227-236. PubMed ID: 27916694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerated cellulose capsules for controlled drug delivery: Part III. Developing a fabrication method and evaluating extemporaneous utility for controlled-release.
    Bhatt B; Kumar V
    Eur J Pharm Sci; 2016 Aug; 91():40-9. PubMed ID: 27262541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
    Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
    Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug.
    Philip A; Pathak K
    PDA J Pharm Sci Technol; 2007; 61(1):24-36. PubMed ID: 17390701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume of water-filled pores in the ethyl cellulose membrane and the permeability of microcapsules.
    Vidmar V; Jalsenjak I; Kondo T
    J Pharm Pharmacol; 1982 Jul; 34(7):411-4. PubMed ID: 6126534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmotic delivery of flurbiprofen through controlled porosity asymmetric membrane capsule.
    Choudhury PK; Chauhan CS; Ranawat MS
    Drug Dev Ind Pharm; 2007 Oct; 33(10):1135-41. PubMed ID: 17963115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets.
    Cuppok Y; Muschert S; Marucci M; Hjaertstam J; Siepmann F; Axelsson A; Siepmann J
    Int J Pharm; 2011 May; 409(1-2):30-7. PubMed ID: 21354465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of dual-responsive cellulose-based membrane via simplified surface-initiated ATRP.
    Qiu X; Ren X; Hu S
    Carbohydr Polym; 2013 Feb; 92(2):1887-95. PubMed ID: 23399233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on electrochemical characterization and performance prediction of cellulose acetate and Zeocarb-225 composite membranes in aqueous NaCl solutions.
    Tiwari AK; Ahmad S
    J Colloid Interface Sci; 2006 Jun; 298(1):274-81. PubMed ID: 16499917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coupling of solute fluxes in membranes.
    Galey WR; Van Bruggen JT
    J Gen Physiol; 1970 Feb; 55(2):220-42. PubMed ID: 5413079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of geometrical and chemical constraints on water flux across artificial membranes.
    Gary-Bobo CM; Solomon AK
    J Gen Physiol; 1971 May; 57(5):610-22. PubMed ID: 5553104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a dosage form for accelerated release.
    Waldner C; Friedl HE; Dünnhaupt S; Köllner S; Leonaviciute G; Bernkop-Schnürch A
    Int J Pharm; 2014 Aug; 471(1-2):189-96. PubMed ID: 24834878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and drug-permeation profiles of microporous and dense cellulose acetate membranes: influence of plasticizer and pore forming agent.
    Meier MM; Kanis LA; Soldi V
    Int J Pharm; 2004 Jun; 278(1):99-110. PubMed ID: 15158953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
    Choudhury PK; Ranawat MS; Pillai MK; Chauhan CS
    Acta Pharm; 2007 Sep; 57(3):343-50. PubMed ID: 17878113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotic, diffusive and convective volume and solute flows of ionic solutions through a horizontally mounted polymeric membrane.
    Jasik-Slezak J; Grzegorczyn S; Slezak A
    Polim Med; 2007; 37(3):31-46. PubMed ID: 18251203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-propranolol imprinted polymer nanoparticle-on-microsphere composite porous cellulose membrane for the enantioselectively controlled delivery of racemic propranolol.
    Jantarat C; Tangthong N; Songkro S; Martin GP; Suedee R
    Int J Pharm; 2008 Feb; 349(1-2):212-25. PubMed ID: 17766067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filtration, diffusion, and molecular sieving through porous cellulose membranes.
    RENKIN EM
    J Gen Physiol; 1954 Nov; 38(2):225-43. PubMed ID: 13211998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmotic capsules: A universal oral, controlled-release drug delivery dosage form.
    Waterman KC; Goeken GS; Konagurthu S; Likar MD; MacDonald BC; Mahajan N; Swaminathan V
    J Control Release; 2011 Jun; 152(2):264-9. PubMed ID: 21315121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.